Progress in stem cell-derived technologies for hepatocellular carcinoma
Rajagopal N AravalliDepartment of Radiology, University of Minnesota Medical School, Minneapolis, MN, USAAbstract: Primary hepatocellular carcinoma (HCC) is a common malignancy that has a poor prognosis because it is often diagnosed at an advanced stage. HCC normally develops as a consequence of und...
Guardado en:
Autor principal: | Rajagopal N Aravalli |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c8073b7f772b4d6c8233527cd2bf8bed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Linc-ROR facilitates progression and angiogenesis of hepatocellular carcinoma by modulating DEPDC1 expression
por: Chuan Tian, et al.
Publicado: (2021) -
Long non-coding RNA HOMER3-AS1 drives hepatocellular carcinoma progression via modulating the behaviors of both tumor cells and macrophages
por: Jian Pu, et al.
Publicado: (2021) -
Roles of Therapeutic Bioactive Compounds in Hepatocellular Carcinoma
por: Divya Jain, et al.
Publicado: (2021) -
Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities
por: Thorsten R Doeppner, et al.
Publicado: (2010) -
The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Jianyong Zhuo, et al.
Publicado: (2021)